Rate and predictive factors of spontaneous hepatitis C virus clearance after acute infection in human immunodeficiency virus-positive subjects

Michele Merli(University of Insubria), Hamid Hasson(Vita-Salute San Raffaele University), Albino Poli, Maria Rita Parisi(Vita-Salute San Raffaele University), Emanuela Messina(Vita-Salute San Raffaele University), Andrea Andolina, Antonella Castagna(Vita-Salute San Raffaele University), Laura Galli(Vita-Salute San Raffaele University), Sabrina Bagaglio(Vita-Salute San Raffaele University), Giulia Morsica(Vita-Salute San Raffaele University), Stefania Salpietro(IRCCS Ospedale San Raffaele), Caterina Uberti‐Foppa(Vita-Salute San Raffaele University), Adriano Lazzarin(Vita-Salute San Raffaele University)
Journal of Hepatology
January 1, 2017
10.1016/s0168-8278(17)30873-5
Cited by 1

Related Papers

Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and Australia
|New England Journal of Medicine|2003|653
Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial
|The Lancet|2009|620
Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV
|The Lancet|1992|393
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors
|Clinical Microbiology and Infection|2020|391
Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE)
|PLoS Medicine|2013|362